Serum‐derived albumin as a cryoprotective agent for the long‐term storage of red blood cells: A preliminary examination
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
BACKGROUND: Cryopreservation extends the shelf life of red blood cells (RBC) from weeks to years, offering major advantages for blood banking logistics, especially in remote environments. However, current glycerol-based methods, though effective, are limited in scope due to complex post-thaw washing and incompatibility with routine clinical workflows. This study evaluated plasma-derived albumin as a potential alternative cryoprotective agent (CPA) for human RBC. STUDY DESIGN AND METHODS: Donor-derived RBC were suspended in 25% w/v bovine serum albumin (BSA) prepared in various diluents and tested for biocompatibility and cryoprotective efficacy under rapid freezing (immersion in liquid nitrogen) and gradual freezing with storage at -80°C. Post-thaw recovery was quantified by measuring hemolysis after resuscitation of frozen cells to 37°C. RESULTS: Albumin-based media were non-toxic, maintaining >99% RBC recovery prior to freezing. When rapidly frozen, albumin conferred strong cryoprotection (≥95% recovery) in salt-rich diluents such as SAG-M, Hartmann's, and Alsever's solutions, exceeding that of glycerol-based CPA (77 ± 25%). Albumin's cryopreservative efficacy was enhanced in ionic media of neutral pH but was absent entirely under gradual freezing (
Fields of Study & Subjects
Blood transfusion and management
Trauma
Hemostasis
Coagulopathy
Resuscitation
Blood groups and transfusion
Publication details
- Journal / source
- Transfusion
- Volume
- 66
- Issue
- S1
- Pages
- S310–S320
- Publication date
- 30 March 2026
- Language
- EN